These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 20832995

  • 1. Impulsivity and sensation seeking in cannabis abusing patients with schizophrenia.
    Dervaux A, Goldberger C, Gourion D, Bourdel MC, Laqueille X, Lôo H, Olié JP, Krebs MO.
    Schizophr Res; 2010 Nov; 123(2-3):278-80. PubMed ID: 20832995
    [No Abstract] [Full Text] [Related]

  • 2. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia?
    Dervaux A, Baylé FJ, Laqueille X, Bourdel MC, Le Borgne MH, Olié JP, Krebs MO.
    Am J Psychiatry; 2001 Mar; 158(3):492-4. PubMed ID: 11229997
    [Abstract] [Full Text] [Related]

  • 3. Cannabis use and schizophrenia.
    Krebs MO, Goldberger C, Dervaux A.
    Am J Psychiatry; 2005 Feb; 162(2):401-2; author reply 402. PubMed ID: 15677615
    [No Abstract] [Full Text] [Related]

  • 4. Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients.
    Zhornitsky S, Rizkallah E, Pampoulova T, Chiasson JP, Lipp O, Stip E, Potvin S.
    Psychiatry Res; 2012 Dec 30; 200(2-3):237-41. PubMed ID: 22980481
    [Abstract] [Full Text] [Related]

  • 5. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.
    de Win MM, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W.
    J Psychopharmacol; 2006 Mar 30; 20(2):226-35. PubMed ID: 16510480
    [Abstract] [Full Text] [Related]

  • 6. Cannabis use and age at onset of schizophrenia.
    Veen ND, Selten JP, van der Tweel I, Feller WG, Hoek HW, Kahn RS.
    Am J Psychiatry; 2004 Mar 30; 161(3):501-6. PubMed ID: 14992976
    [Abstract] [Full Text] [Related]

  • 7. Tobacco, alcohol and cannabis use in Tunisian patients with schizophrenia.
    Laqueille X, Ghodhbane S, Nacef F, Choubani Z, Nehdi M, Douki S, Dervaux A.
    Schizophr Res; 2008 Jan 30; 98(1-3):327-8. PubMed ID: 17689929
    [No Abstract] [Full Text] [Related]

  • 8. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls.
    Schaub M, Fanghaenel K, Stohler R.
    Aust N Z J Psychiatry; 2008 Dec 30; 42(12):1060-5. PubMed ID: 19016094
    [Abstract] [Full Text] [Related]

  • 9. Risk-taking in schizophrenia and controls with and without cannabis dependence.
    Fischer BA, McMahon RP, Kelly DL, Wehring HJ, Meyer WA, Feldman S, Carpenter WT, Gorelick DA.
    Schizophr Res; 2015 Feb 30; 161(2-3):471-7. PubMed ID: 25467541
    [Abstract] [Full Text] [Related]

  • 10. Cannabis use and schizophrenia.
    Wade D.
    Am J Psychiatry; 2005 Feb 30; 162(2):401; author reply 402. PubMed ID: 15677616
    [No Abstract] [Full Text] [Related]

  • 11. Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome.
    Rosen JL, Miller TJ, D'Andrea JT, McGlashan TH, Woods SW.
    Schizophr Res; 2006 Jul 30; 85(1-3):124-31. PubMed ID: 16650735
    [Abstract] [Full Text] [Related]

  • 12. Cannabis abuse and the course of recent-onset schizophrenic disorders.
    Linszen DH, Dingemans PM, Lenior ME.
    Arch Gen Psychiatry; 1994 Apr 30; 51(4):273-9. PubMed ID: 8161287
    [Abstract] [Full Text] [Related]

  • 13. Novelty-seeking among schizophrenia patients with comorbid alcohol abuse.
    Kim JH, Kim D, Park SH, Lee HB, Chung EK.
    J Nerv Ment Dis; 2007 Jul 30; 195(7):622-4. PubMed ID: 17632255
    [Abstract] [Full Text] [Related]

  • 14. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
    Corcoran CM, Kimhy D, Stanford A, Khan S, Walsh J, Thompson J, Schobel S, Harkavy-Friedman J, Goetz R, Colibazzi T, Cressman V, Malaspina D.
    Schizophr Res; 2008 Dec 30; 106(2-3):286-93. PubMed ID: 18809298
    [Abstract] [Full Text] [Related]

  • 15. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.
    Dubertret C, Bidard I, Adès J, Gorwood P.
    Schizophr Res; 2006 Sep 30; 86(1-3):284-90. PubMed ID: 16806837
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.
    Koskinen J, Löhönen J, Koponen H, Isohanni M, Miettunen J.
    Schizophr Bull; 2010 Nov 30; 36(6):1115-30. PubMed ID: 19386576
    [Abstract] [Full Text] [Related]

  • 18. Temperament and substance abuse in schizophrenia: is there a relationship?
    Van Ammers EC, Sellman JD, Mulder RT.
    J Nerv Ment Dis; 1997 May 30; 185(5):283-8. PubMed ID: 9171804
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High potency cannabis: a risk factor for dependence, poor psychosocial outcomes, and psychosis.
    Hall W, Degenhardt L.
    BMJ; 2015 Mar 04; 350():h1205. PubMed ID: 25739398
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.